The role of changes in systemic inflammatory response markers during neoadjuvant chemotherapy in predicting suboptimal surgery in ovarian cancer

Gulseren V., Cakir I., Ozdemir I. A., Sanci M., Gokcu M., Gungorduk K.

CURRENT PROBLEMS IN CANCER, vol.44, no.4, 2020 (SCI-Expanded) identifier identifier identifier


Aim: The aim of this study was to investigate the possibility of using the neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio, and platelet count and their dynamic changes during chemotherapy to predict suboptimal interval debulking surgery (IDS) in stage IIIC-IVA serous ovarian cancer (OC).